Cost of disorders of the brain in Europe.
By M. De Hert, J. Peuskens. European Journal of Neurology, 2006
1,194 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/0de27e13a09637ec4a30e106a29f9304146ce9ed
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. M. Ruscio
- K. Shear
- Ronald C. Kessler
- Bruno Dubois
- M. Steenkamp
- M. Linde
- T. J. Steiner
- E. Blessing
Citations in the corpus
- Pathophysiology of Migraine: A Disorder of Sensory Processing. (2017, background): “6 (757) and the European Union €27 billion (43) annually.”
- Epidemiology of anxiety disorders. (2010, background): “Because of these differences in exposure, lifetime prevalence of PTSD is estimated to be only 1–2% in Western Europe, 6–9% in North America, and over 10% in countries that have been exposed to long-term sectarian violence.”
- Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline (2007, background): “Europe related to dementia amount to at least 55 billion € per year, not including indirect costs and costs in young patients with dementia [1,3], and the majority of the costs are spent on institutional care.”
- The cost of headache disorders in Europe: the Eurolight project (2012, background): “Given their high prevalence, it has been suggested that non-migrainous headache disorders are at least as costly as migraine [2].”
- The economic cost of brain disorders in Europe (2012, methodology): “Despite these uncertainties, data for each individual country are probably reasonably precise because of the use of our robust health economic model [5].”
- Cannabidiol as a Potential Treatment for Anxiety Disorders (2015, background): “Together, they have a lifetime prevalence in the USA of 29 % [4], the highest of any mental disorder, and constitute an immense social and economic burden [5, 6].”
- Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies. (2005, background): “These data, despite some diagnosis-specific differences, highlight a substantial degree of functional disability and overall burden, even for seemingly ‘‘less serious’’ disorders (Andlin-Sobocki et al., 2005).”
- The size and burden of mental disorders and other disorders of the brain in Europe 2010. (2011, methodology): “…(ECNP), involving multiple task forces and panels, and using sophisticated methodological approaches including reanalyses of data sets from epidemiological studies in the EU3 up to the year 2004, which resulted in a series of publications (Andlin-Sobocki et al., 2005; Wittchen et al., 2005).”